{"id":60754,"date":"2025-02-08T22:02:24","date_gmt":"2025-02-08T21:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/"},"modified":"2025-02-08T22:02:24","modified_gmt":"2025-02-08T21:02:24","slug":"global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/","title":{"rendered":"Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<b><i>GHLF Urges Greater Transparency and Patient Protections<\/i><\/b><\/p>\n<p>UPPER NYACK, N.Y.&#8211;(BUSINESS WIRE)&#8211;The Global Healthy Living Foundation (GHLF), a leading worldwide patient advocacy organization, is raising concerns about the lack of full disclosure in the Hims &amp; Hers Health Super Bowl ad to be aired tomorrow night. The ad promotes, without identifying, semaglutide, the compounded versions of the weight-loss drugs Ozempic and Wegovy, and tirzepatide, the compounded version of Zepbound.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250208077324\/en\/1948855\/4\/GHLF_logo_ghlf.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250208077324\/en\/1948855\/22\/GHLF_logo_ghlf.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250208077324\/en\/1948855\/4\/GHLF_logo_ghlf.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250208077324\/en\/1948855\/21\/GHLF_logo_ghlf.jpg\"><\/a><\/p>\n<p>\nWhile the ad describes the unnamed product\u2019s benefits, it does not provide the viewer with the full safety information because technically it doesn\u2019t have to. It is compounded, not an FDA-approved brand-name drug, so it only directs viewers to its website &#8212; which is not identified &#8212; in a three-second, light gray, small-type message at the end of the two $7 million commercials scheduled to air.<\/p>\n<p>\n\u201cA brief, hard-to-read disclaimer flashes on-screen for a few seconds with no accompanying audio. It fails to ensure patients understand the critical differences between compounded and FDA-approved medications and fails to provide safety information in the commercial itself,\u201d said Steven Newmark, GHLF\u2019s Chief Policy and Legal Officer.<\/p>\n<p>\nTwo Senators, Dick Durbin (D-Illinois) and Roger Marshall (R-Kansas) sent a letter Friday morning to FDA acting Commissioner Sara Brenner pointing out this patient safety loophole. They wrote that they worry that the Hims &amp; Hers Health ad, which will be seen by millions of people during the big game on Sunday, \u201crisks misleading patients by omitting any safety or side effect information\u201d about the compounded weight loss drugs that it promotes.<\/p>\n<p>\n\u201cWe applaud these Senators&#8217; actions,\u201d Mr. Newmark said. \u201cAnd their plan to \u2018introduce bipartisan legislation to close this regulatory loophole for the FDA\u2019s authorities \u2026 so that patients are not deceived by advertisements that glaringly omit critical safety and side effect information.\u2019\u201d (The Durbin\/Marshall letter is <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.durbin.senate.gov%2Fimo%2Fmedia%2Fdoc%2FDurbin-Marshall_FDA%2520Letter_SB-DTC%2520Telehealth%2520Ad-output%2520FINAL.pdf&amp;esheet=54202298&amp;newsitemid=20250208077324&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=56972d75a5d6fefbdf725e5d141ef239\" rel=\"nofollow\" shape=\"rect\">here<\/a>.)<\/p>\n<p>\nCompanies such as Hims &amp; Hers Health, Ro and Noom use loopholes in the law that allow FDA-approved drugs to be compounded to meet market demand. But this loophole does not require the same safety and side effects disclosures.<\/p>\n<p>\n\u201cWhen a medication is being marketed for widespread use, particularly one that involves weight loss and serious health implications, whether it is compounded or not, a full and transparent safety and side-effects disclosure must be prominent and accessible,\u201d GHLF\u2019s Chief Science Policy Officer, Robert Popovian, PharmD, said.<\/p>\n<p>\n\u201cViewers should not have to hunt for critical safety information in fine print that they may never see,\u201d Popovian added.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMedia Contact:<br \/>\n<br \/>Louis Tharp<br \/>\n<br \/><a target=\"_blank\" href=\"mailto:LTHAR&#80;&#64;&#71;&#72;&#76;&#70;&#46;&#79;&#82;&#71;\" rel=\"nofollow\" shape=\"rect\">&#76;&#x54;&#x48;A&#82;&#x50;&#64;&#71;&#x48;&#x4c;&#70;&#x2e;&#x4f;R&#71;<\/a><br \/>845-323-8408<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>GHLF Urges Greater Transparency and Patient Protections UPPER NYACK, N.Y.&#8211;(BUSINESS WIRE)&#8211;The Global Healthy Living Foundation (GHLF), a leading worldwide patient advocacy organization, is raising concerns about the lack of full disclosure in the Hims &amp; Hers Health Super Bowl ad to be aired tomorrow night. The ad promotes, without identifying, semaglutide, the compounded versions of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60754","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"GHLF Urges Greater Transparency and Patient Protections UPPER NYACK, N.Y.&#8211;(BUSINESS WIRE)&#8211;The Global Healthy Living Foundation (GHLF), a leading worldwide patient advocacy organization, is raising concerns about the lack of full disclosure in the Hims &amp; Hers Health Super Bowl ad to be aired tomorrow night. The ad promotes, without identifying, semaglutide, the compounded versions of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-08T21:02:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250208077324\/en\/1948855\/22\/GHLF_logo_ghlf.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug\",\"datePublished\":\"2025-02-08T21:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/\"},\"wordCount\":442,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250208077324\\\/en\\\/1948855\\\/22\\\/GHLF_logo_ghlf.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/\",\"name\":\"Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250208077324\\\/en\\\/1948855\\\/22\\\/GHLF_logo_ghlf.jpg\",\"datePublished\":\"2025-02-08T21:02:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250208077324\\\/en\\\/1948855\\\/22\\\/GHLF_logo_ghlf.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250208077324\\\/en\\\/1948855\\\/22\\\/GHLF_logo_ghlf.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/","og_locale":"en_US","og_type":"article","og_title":"Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug - Pharma Trend","og_description":"GHLF Urges Greater Transparency and Patient Protections UPPER NYACK, N.Y.&#8211;(BUSINESS WIRE)&#8211;The Global Healthy Living Foundation (GHLF), a leading worldwide patient advocacy organization, is raising concerns about the lack of full disclosure in the Hims &amp; Hers Health Super Bowl ad to be aired tomorrow night. The ad promotes, without identifying, semaglutide, the compounded versions of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/","og_site_name":"Pharma Trend","article_published_time":"2025-02-08T21:02:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250208077324\/en\/1948855\/22\/GHLF_logo_ghlf.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug","datePublished":"2025-02-08T21:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/"},"wordCount":442,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250208077324\/en\/1948855\/22\/GHLF_logo_ghlf.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/","url":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/","name":"Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250208077324\/en\/1948855\/22\/GHLF_logo_ghlf.jpg","datePublished":"2025-02-08T21:02:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250208077324\/en\/1948855\/22\/GHLF_logo_ghlf.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250208077324\/en\/1948855\/22\/GHLF_logo_ghlf.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-healthy-living-foundation-says-hims-hers-health-super-bowl-ad-omits-risks-of-weight-loss-drug\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Healthy Living Foundation Says Hims &amp; Hers Health Super Bowl Ad Omits Risks of Weight Loss Drug"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60754","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60754"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60754\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60754"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60754"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60754"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}